Abstract
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Journal of Psychiatric Research |
| Jahrgang | 82 |
| Seiten (von - bis) | 126-135 |
| Seitenumfang | 10 |
| ISSN | 0022-3956 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 01.11.2016 |
Fördermittel
This study was supported by grants from the National Institute of Mental Health (R01MH092290 to LWB; R01MH092291 to SK; R01MH092292 to BJC; R01MH092293 to GAH and JAT; R01MH092513 to SHZ; R01MH092516 to DEG; R01MH092520 DLG; R01MH092289 to MWS; K08MH099424 to TVF) and NJCTS (NJ Center for Tourette Syndrome and Associated Disorders; to GAH and JAT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was additionally supported by grants from Spain (to PM): the Instituto de Salud Carlos III (PI10/01674, PI13/01461), the Consejería de Economía, Innovación, Ciencia y Empresa de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0741/2010, PI-0437-2012, PI-0471-2013), the Sociedad Andaluza de Neurología, the Fundación Alicia Koplowitz, the Fundación Mutua Madrileña and the Jaques and Gloria Gossweiler Foundation; grants from Germany (to AM): Deutsche Forschungsgemeinschaft (DFG: MU 1692/3-1, MU 1692/4-1 and project C5 of the SFB 936). This research was also supported in part by an Informatics Starter Grant from the PhRMA Foundation (to YB). None of the study sponsors were involved in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication. Dr. Gilbert has received honoraria from the Tourette Syndrome Association/Centers for Disease Control and Prevention and the American Academy of Pediatrics; has received book royalties from Elsevier, and one-time consulting fees for clinical trial design from Teva/Auspex pharmaceuticals, and has received compensation for expert testimony for the U.S. D.O.J. D.V.I.C. program. Dr. Gilbert has also received research support (for Tourette Syndrome, ADHD) from the NIH (NIMH R01 MH092520, NIMH R01 MH081854, NIMH R01 104651, NINDS R01 NS085023), and from Ecopipam Pharmaceuticals (clinical trial, Tourette Syndrome). Dr. Maras is a speaker, consultant for Lilly, Neurim, and Janssen. The following authors reported no biomedical financial interests or potential conflicts of interest: Mohamed Abdulkadir, Lawrence W. Brown, Keun-Ah Cheon, Barbara J. Coffey, Sebastian F.T.M. de Bruijn, Andrea Dietrich, Lonneke Elzerman, Thomas V. Fernandez, Blanca Garcia-Delgar, Dorothy E. Grice, Julie Hagstrøm, Tammy Hedderly, Gary A. Heiman, Isobel Heyman, Pieter J. Hoekstra, Hyun Ju Hong, Chaim Huyser, Laura Ibanez-Gomez, Young Key Kim, Young-Shin Kim, Robert King, Yun-Joo Koh, Sodahm Kook, Samuel Kuperman, Andreas Lamerz, Bennett L. Leventhal, Andrea G. Ludolph, Marcos Madruga-Garrido, Marieke D. Messchendorp, Pablo Mir, Astrid Morer, Alexander Münchau, Tara L. Murphy, Thaïra J.C. Openneer, Kerstin J. Plessen, Judith J.G. Rath, Veit Roessner, Odette Fründt, Eun-Young Shin, Deborah A. Sival, Dong-Ho Song, Jungeun Song, Matthew W. State, Anne-Marie Stolte, Jay A. Tischfield, Jennifer Tübing, Els van den Ban, Frank Visscher, Sina Wanderer, Martin Woods, and Samuel H. Zinner.
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)